CORT vs. STX

Last updated Jun 9, 2026

CORT (Corcept Therapeutics Incorporated) and STX (Seagate Technology plc) are both stocks. CORT operates in Biotechnology (Healthcare), while STX operates in Computer Hardware (Technology). Over the past 10 years, CORT returned 29.33%/yr vs 49.93%/yr for STX. At a 0.19 correlation, their price movements are largely independent.

Performance

CORT vs. STX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and Seagate Technology plc (STX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CORT achieves a 110.72% return, which is significantly lower than STX's 218.93% return. Over the past 10 years, CORT has underperformed STX with an annualized return of 29.33%, while STX has yielded a comparatively higher 49.93% annualized return.

CORT

• 1D: 0.98%
• 1M: 40.26%
• YTD: 110.72%
• 6M: -11.63%
• 1Y: 5.36%
• 3Y*: 46.50%
• 5Y*: 27.35%
• 10Y*: 29.33%

STX

• 1D: 3.46%
• 1M: 12.03%
• YTD: 218.93%
• 6M: 208.54%
• 1Y: 599.43%
• 3Y*: 149.84%
• 5Y*: 59.24%
• 10Y*: 49.93%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CORT vs. STX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CORT Corcept Therapeutics Incorporated	110.72%	-30.94%	55.14%	59.92%	2.58%	-24.31%	116.20%	-9.43%	-26.02%	148.76%
STX Seagate Technology plc	218.93%	225.26%	4.06%	69.12%	-51.42%	87.50%	10.14%	62.14%	-2.90%	16.67%

Correlation

The correlation between CORT and STX is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.25
Correlation (10Y) Calculated over the trailing 10-year period	0.26
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004	0.19

Fundamentals

Market Cap CORT : $7.66B STX : $199.90B
EPS CORT : $0.41 STX : $10.58
PE Ratio CORT : 178.81 STX : 82.87
PEG Ratio CORT : 89.07 STX : 0.99
PS Ratio CORT : 11.07 STX : 17.90
PB Ratio CORT : 12.00 STX : 182.56
Total Revenue (TTM) CORT : $769.10M STX : $11.01B
Gross Profit (TTM) CORT : $755.64M STX : $4.57B
EBITDA (TTM) CORT : $3.66M STX : $2.59B

Return for Risk

CORT vs. STX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CORT

CORT Risk / Return Rank: 47
CORT Sharpe Ratio Rank: 44
CORT Sortino Ratio Rank: 47
CORT Omega Ratio Rank: 56
CORT Calmar Ratio Rank: 44
CORT Martin Ratio Rank: 44

STX

STX Risk / Return Rank: 99
STX Sharpe Ratio Rank: 100
STX Sortino Ratio Rank: 99
STX Omega Ratio Rank: 98
STX Calmar Ratio Rank: 100
STX Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CORT vs. STX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Seagate Technology plc (STX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CORT	STX	Difference
Sharpe ratio: Return per unit of total volatility	0.07	9.54	-9.47
Sortino ratio: Return per unit of downside risk	0.66	6.19	-5.53
Omega ratio: Gain probability vs. loss probability	1.14	1.80	-0.66
Calmar ratio: Return relative to maximum drawdown	0.08	28.81	-28.72
Martin ratio: Return relative to average drawdown	0.15	84.36	-84.20
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CORT vs. STX - Sharpe Ratio Comparison

The current CORT Sharpe Ratio is 0.07, which is lower than the STX Sharpe Ratio of 9.54. The chart below compares the historical Sharpe Ratios of CORT and STX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CORT	STX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.07	9.54	-9.47
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.37	1.34	-0.97
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.44	1.19	-0.75
Sharpe Ratio (All Time) Calculated using the full available price history	0.11	0.53	-0.42

Drawdowns

CORT vs. STX - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.28%, which is greater than STX's maximum drawdown of -88.74%. Use the drawdown chart below to compare losses from any high point for CORT and STX.

Drawdown Indicators

	CORT	STX	Difference
Max Drawdown Largest peak-to-trough decline	-94.28%	-88.74%	-5.54%
Max Drawdown (1Y) Largest decline over 1 year	-64.40%	-21.00%	-43.40%
Max Drawdown (3Y) Largest decline over 3 years	-71.85%	-40.00%	-31.85%
Max Drawdown (5Y) Largest decline over 5 years	-71.85%	-56.99%	-14.86%
Max Drawdown (10Y) Largest decline over 10 years	-71.85%	-56.99%	-14.86%
Current Drawdown Current decline from peak	-35.80%	-6.80%	-29.00%
Average Drawdown Average peak-to-trough decline	-53.44%	-26.45%	-26.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.34%	7.16%	+28.18%

Volatility

CORT vs. STX - Volatility Comparison

The current volatility for Corcept Therapeutics Incorporated (CORT) is 16.41%, while Seagate Technology plc (STX) has a volatility of 17.98%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than STX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CORT	STX	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.41%	17.98%	-1.57%
Volatility (6M) Calculated over the trailing 6-month period	85.07%	49.95%	+35.12%
Volatility (1Y) Calculated over the trailing 1-year period	76.73%	63.55%	+13.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	74.52%	44.63%	+29.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	67.22%	42.18%	+25.04%

Dividends

CORT vs. STX - Dividend Comparison

CORT has not paid dividends to shareholders, while STX's dividend yield for the trailing twelve months is around 0.33%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CORT Corcept Therapeutics Incorporated	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
STX Seagate Technology plc	0.33%	1.05%	3.27%	3.28%	5.32%	2.40%	4.21%	4.27%	6.53%	6.02%	6.60%	6.14%

Financials

CORT vs. STX - Profitability Comparison

The chart below illustrates the profitability comparison between Corcept Therapeutics Incorporated and Seagate Technology plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.

STX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported a gross profit of 1.45B and revenue of 3.11B. Therefore, the gross margin over that period was 46.5%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.

STX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported an operating income of 982.00M and revenue of 3.11B, resulting in an operating margin of 31.6%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.

STX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Seagate Technology plc reported a net income of 748.00M and revenue of 3.11B, resulting in a net margin of 24.0%.

Frequently Asked Questions

Can I hold both CORT and STX in my portfolio?

CORT and STX have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CORT or STX?

STX has higher volatility (17.98%) compared to CORT (16.41%). In terms of maximum drawdown, CORT dropped -94.28% vs STX's -88.74%.

Which has better risk-adjusted returns?

STX currently has the higher Sharpe Ratio (9.54 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.